Steven Mah

Managing Director, Health Care - Life Science & Diagnostic Tools

Headshot photo of Steven Mah

Steven Mah is a Managing Director on the Equity Research team in the life science & diagnostic tools sector. Prior to joining Cowen, Dr. Mah was a senior analyst for life science & diagnostic tools at Piper Sandler, and earlier in his career was a Principal in Piper Sandler’s health care investment banking group, where he focused on mergers and acquisitions as well as equity and equity-linked transactions.

At Cowen his expertise in dynamic emerging market segments such as synthetic biology and artificial-intelligence driven health solutions will further the health care research sector.

Dr. Mah holds a B.S. in molecular biology from the University of California, Los Angeles; a Ph.D. in molecular biology from the University of California, San Diego; and an MBA from Cornell University’s Johnson Graduate School of Management.

Get In Touch

Start a conversation with Steven Mah


    Explore related thought leadership, reports, coverage and insights for Steven Mah.

    Best ESG Investment Ideas for 2023

    Robotic Arm carrying a pull bottle. Representing the impact of AI on pharma R&D.
    Ahead of the Curve®

    Speeding Innovation: A Primer on AI in Pharma R&D

    Representing research into Obesity drug market is a scale and an exhausted tape measure resting on the scale. Against a white background and the scale is old fashioned.
    Ahead of the Curve®

    Obesity Market Poised to Deliver on Outsized Potential